Mingyun Chen

729 total citations
32 papers, 509 citations indexed

About

Mingyun Chen is a scholar working on Electrical and Electronic Engineering, Molecular Biology and Epidemiology. According to data from OpenAlex, Mingyun Chen has authored 32 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Electrical and Electronic Engineering, 7 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Mingyun Chen's work include Liver Disease Diagnosis and Treatment (6 papers), Multilevel Inverters and Converters (6 papers) and Silicon Carbide Semiconductor Technologies (5 papers). Mingyun Chen is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Multilevel Inverters and Converters (6 papers) and Silicon Carbide Semiconductor Technologies (5 papers). Mingyun Chen collaborates with scholars based in China, Canada and Singapore. Mingyun Chen's co-authors include Yigang He, Lianxi Li, Weiping Jia, Tingting Li, Junxi Lu, Yuqian Bao, Meifang Li, Yue Zhu, Alun Gu and Zongqiang Mao and has published in prestigious journals such as NeuroImage, Scientific Reports and IEEE Transactions on Power Electronics.

In The Last Decade

Mingyun Chen

31 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingyun Chen China 14 141 94 79 66 65 32 509
Chengning Zhang China 18 484 3.4× 179 1.9× 106 1.3× 43 0.7× 177 2.7× 83 997
Jianxin Tan China 15 85 0.6× 349 3.7× 50 0.6× 21 0.3× 19 0.3× 68 984
Tatsuo Tani Japan 15 199 1.4× 407 4.3× 25 0.3× 65 1.0× 25 0.4× 57 1.1k
Weiwei Xie China 14 106 0.8× 153 1.6× 140 1.8× 13 0.2× 5 0.1× 37 628
Ningjie Zhang China 14 149 1.1× 229 2.4× 71 0.9× 98 1.5× 36 0.6× 24 648
Hidekazu Kondo Japan 18 59 0.4× 241 2.6× 56 0.7× 123 1.9× 22 0.3× 79 1.0k
Hyun Koo Yoon South Korea 14 184 1.3× 122 1.3× 31 0.4× 57 0.9× 12 0.2× 30 652
Hiroaki Sato Japan 16 65 0.5× 155 1.6× 71 0.9× 72 1.1× 47 0.7× 79 844
Yanlin Chen China 15 28 0.2× 162 1.7× 75 0.9× 90 1.4× 15 0.2× 84 767
Jesús Á. Oliver Spain 12 85 0.6× 76 0.8× 31 0.4× 19 0.3× 172 2.6× 13 487

Countries citing papers authored by Mingyun Chen

Since Specialization
Citations

This map shows the geographic impact of Mingyun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyun Chen more than expected).

Fields of papers citing papers by Mingyun Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingyun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyun Chen. The network helps show where Mingyun Chen may publish in the future.

Co-authorship network of co-authors of Mingyun Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Mingyun Chen. A scholar is included among the top collaborators of Mingyun Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingyun Chen. Mingyun Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Mingyun, et al.. (2025). Epiberberine ameliorates ulcerative colitis by regulating bile acids hepatoenteral circulation through intestinal FXR. Phytomedicine. 143. 156831–156831. 3 indexed citations
3.
Chen, Lin, et al.. (2024). Sarmentol H derived from Sedum sarmentosum Bunge directly targets FXR to mitigate cholestasis by recruiting SRC-1. Phytomedicine. 130. 155759–155759. 3 indexed citations
4.
Gu, Alun, et al.. (2023). Advantages and challenges of China's participation in international hydrogen trade. International Journal of Hydrogen Energy. 52. 1356–1368. 18 indexed citations
5.
Dai, Guangyan, Zhiqiang Guo, Jeffery A. Jones, et al.. (2023). Right, but not left, posterior superior temporal gyrus is causally involved in vocal feedback control. NeuroImage. 278. 120282–120282. 6 indexed citations
6.
Wang, Junwei, et al.. (2023). High-normal serum bilirubin decreased the risk of lower limb atherosclerosis in type 2 diabetes: a real-world study. Diabetology & Metabolic Syndrome. 15(1). 105–105. 4 indexed citations
7.
Shen, Ximei, et al.. (2023). Suppression of TLR4 prevents diabetic bone loss by regulating FTO-mediated m6A modification. International Immunopharmacology. 122. 110510–110510. 13 indexed citations
8.
Chen, Mingyun, Zhihui Zhang, Jiang-Feng Ke, et al.. (2022). Chaetocin attenuates atherosclerosis progression and inhibits vascular smooth muscle cell phenotype switching. Journal of Cardiovascular Translational Research. 15(6). 1270–1282. 10 indexed citations
9.
Liu, Die, Mingyun Chen, Wei Zong, et al.. (2022). Effects of Sedi Herba (Sedum sarmentosum) on attenuating cholestasis by the activation of the farnesoid x receptor (FXR)-mediated signaling. Biomedicine & Pharmacotherapy. 155. 113803–113803. 8 indexed citations
10.
Chen, Mingyun, Jiang-Feng Ke, Zhihui Zhang, et al.. (2021). Deletion of Fam172a accelerates advanced atherosclerosis and induces plaque instability. Atherosclerosis. 333. 39–47. 7 indexed citations
11.
Liu, Fengjing, Si Chen, Weijing Zhao, et al.. (2021). Urine Uric Acid Excretion Levels are Positively Associated with Obesity and Abdominal Obesity in Type 2 Diabetes Patients without Chronic Kidney Disease. Diabetes Metabolic Syndrome and Obesity. Volume 14. 4691–4703. 10 indexed citations
12.
Li, Meifang, Li Ma, Yue Zhu, et al.. (2020). Adverse maternal and neonatal outcomes in pregnant women with abnormal glucose metabolism. Diabetes Research and Clinical Practice. 161. 108085–108085. 22 indexed citations
13.
Xu, Peipei, Su Zeng, Meifang Li, et al.. (2020). FAM172A promotes follicular thyroid carcinogenesis and may be a marker of FTC. Endocrine Related Cancer. 27(11). 657–669. 11 indexed citations
14.
Wang, Junwei, Aiping Wang, Mingyun Chen, et al.. (2019). Prevalence and clinical characteristics of hypertension and metabolic syndrome in newly diagnosed patients with ketosis-onset diabetes: a cross-sectional study. Diabetology & Metabolic Syndrome. 11(1). 31–31. 9 indexed citations
15.
Chen, Mingyun, Tingting Li, Yue Zhu, et al.. (2017). Serum uric acid levels are associated with obesity but not cardio-cerebrovascular events in Chinese inpatients with type 2 diabetes. Scientific Reports. 7(1). 40009–40009. 53 indexed citations
16.
Wang, Aiping, Lianxi Li, Tingting Li, et al.. (2016). Urine uric acid excretion is associated with nonalcoholic fatty liver disease in patients with type 2 diabetes. Journal of Diabetes and its Complications. 30(6). 1074–1080. 21 indexed citations
17.
Li, Meifang, Tingting Li, Yinfang Tu, et al.. (2016). The coexistence of carotid and lower extremity atherosclerosis further increases cardio-cerebrovascular risk in type 2 diabetes. Cardiovascular Diabetology. 15(1). 43–43. 45 indexed citations
18.
Li, Meifang, Rong Zhang, Tingting Li, et al.. (2015). High Glucose Increases the Expression of Inflammatory Cytokine Genes in Macrophages Through H3K9 Methyltransferase Mechanism. Journal of Interferon & Cytokine Research. 36(1). 48–61. 31 indexed citations
19.
20.
Zhong, Zibiao, Shaojun Ye, Yan Xiong, et al.. (2015). Decreased expression of mitochondrial aldehyde dehydrogenase-2 induces liver injury via activation of the mitogen-activated protein kinase pathway. Transplant International. 29(1). 98–107. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026